Lista de obras - Guillermina Girardi - Dominio Público Uruguay

A new mouse model to explore therapies for preeclampsia

artículo científico publicado en 2010

A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice

artículo científico publicado en 2005

Acetaminophen nephrotoxicity in male Wistar rats

artículo científico publicado en 1992

Activation of complement mediates antiphospholipid antibody-induced pregnancy loss

artículo científico publicado en 2003

An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development

artículo científico publicado en 2010

Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation

artículo científico publicado en 2007

Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.

artículo científico publicado en 2010

Author's response to ‘Statins for the treatment of obstetric complications in Antiphospholipid Syndrome?’

Can statins prevent pregnancy complications?

artículo científico

Cervical remodeling/ripening at term and preterm delivery: the same mechanism initiated by different mediators and different effector cells

artículo científico publicado en 2011

Chapter 5 Tissue Factor in Antiphospholipid Antibody-induced Pregnancy Loss: Thrombosis versus Inflammation

Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss

artículo científico publicado en 2011

Clinical Improvement and Successful Pregnancy in a Preeclamptic Patient With Antiphospholipid Syndrome Treated With Pravastatin

Comparison of the mechanisms responsible for cervical remodeling in preterm and term labor

artículo científico publicado en 2013

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

artículo científico publicado en 2002

Complement C5a is present in CSF of human newborns and is elevated in association with preterm birth.

artículo científico publicado en 2016

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

artículo científico publicado en 2003

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

Complement activation in animal and human pregnancies as a model for immunological recognition

artículo científico publicado en 2011

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction

artículo científico publicado en 2006

Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice

artículo científico publicado en 2011

Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome

artículo científico publicado en 2005

Complement inhibition and statins prevent fetal brain cortical abnormalities in a mouse model of preterm birth.

artículo científico publicado en 2013

Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome

artículo científico publicado en 2016

Complement inhibition keeps mothers calm and avoids fetal rejection

artículo científico publicado en 2008

Effect of different renal glutathione levels on renal mercury disposition and excretion in the rat

artículo científico publicado en 1993

Effectiveness of N-acetylcysteine in protecting against mercuric chloride-induced nephrotoxicity

artículo científico publicado en 1991

Evidence for renal ischaemia as a cause of mercuric chloride nephrotoxicity

article

Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers

artículo científico publicado en 2007

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

artículo científico publicado en 2004

Heparin treatment in pregnancy loss: Potential therapeutic benefits beyond anticoagulation

artículo científico publicado en 2005

Imaging of activated complement using ultrasmall superparamagnetic iron oxide particles (USPIO)--conjugated vectors: an in vivo in utero non-invasive method to predict placental insufficiency and abnormal fetal brain development

artículo científico publicado en 2014

MRI-based methods to detect placental and fetal brain abnormalities in utero

artículo científico publicado en 2015

Mercuric chloride effects on rat renal redox enzymes activities: SOD protection

artículo científico publicado en 1995

Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome

artículo científico publicado en 2008

Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy

artículo científico publicado en 2016

Pravastatin prevents miscarriages in antiphospholipid antibody-treated mice.

artículo científico publicado en 2009

Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury

artículo científico publicado en 2009

REVIEW ARTICLE: Guilty As Charged: All Available Evidence Implicates Complement’s Role in Fetal Demise

artículo científico publicado en 2008

Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia

artículo científico publicado en 2005

Role of complement component C1q in the onset of preeclampsia in mice

artículo científico publicado en 2011

Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies

artículo científico publicado en 2009

Role of tissue factor in feto‐maternal development: a xiphos ⬇️

artículo científico publicado el 1 de febrero de 2011

Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation

artículo científico publicado en 2011

Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome

artículo científico publicado en 2010

Statins prevent cervical remodeling, myometrial contractions and preterm labor through a mechanism that involves hemoxygenase-1 and complement inhibition.

artículo científico publicado en 2014

The Intersection of Maternal Metabolic Syndrome, Adverse Pregnancy Outcomes, and Future Metabolic Health for the Mother and Offspring

artículo científico publicado en 2022

The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients

artículo científico publicado en 2007

The complement system in the pathophysiology of pregnancy

artículo científico publicado en 2006

The role of complement in pregnancy and fetal loss

artículo científico publicado en 2003

Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule

artículo científico publicado en 2008

Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury

artículo científico publicado en 2007

Urinary congophilia in women with hypertensive disorders of pregnancy and preexisting proteinuria or hypertension

artículo científico publicado en 2016

Verapamil Protection against Mercuric Chloride-Induced Renal Glomerular Injury in Rats

artículo científico publicado en 1998

Lista de obras de Guillermina Girardi

A new mouse model to explore therapies for preeclampsia

A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice

Acetaminophen nephrotoxicity in male Wistar rats

Activation of complement mediates antiphospholipid antibody-induced pregnancy loss

An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development

Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation

Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.

Author's response to ‘Statins for the treatment of obstetric complications in Antiphospholipid Syndrome?’

Can statins prevent pregnancy complications?

Cervical remodeling/ripening at term and preterm delivery: the same mechanism initiated by different mediators and different effector cells

Chapter 5 Tissue Factor in Antiphospholipid Antibody-induced Pregnancy Loss: Thrombosis versus Inflammation

Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss

Clinical Improvement and Successful Pregnancy in a Preeclamptic Patient With Antiphospholipid Syndrome Treated With Pravastatin

Comparison of the mechanisms responsible for cervical remodeling in preterm and term labor

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

Complement C5a is present in CSF of human newborns and is elevated in association with preterm birth.

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

Complement activation in animal and human pregnancies as a model for immunological recognition

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction

Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice

Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome

Complement inhibition and statins prevent fetal brain cortical abnormalities in a mouse model of preterm birth.

Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome

Complement inhibition keeps mothers calm and avoids fetal rejection

Effect of different renal glutathione levels on renal mercury disposition and excretion in the rat

Effectiveness of N-acetylcysteine in protecting against mercuric chloride-induced nephrotoxicity

Evidence for renal ischaemia as a cause of mercuric chloride nephrotoxicity

Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

Heparin treatment in pregnancy loss: Potential therapeutic benefits beyond anticoagulation

Imaging of activated complement using ultrasmall superparamagnetic iron oxide particles (USPIO)--conjugated vectors: an in vivo in utero non-invasive method to predict placental insufficiency and abnormal fetal brain development

MRI-based methods to detect placental and fetal brain abnormalities in utero

Mercuric chloride effects on rat renal redox enzymes activities: SOD protection

Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome

Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy

Pravastatin prevents miscarriages in antiphospholipid antibody-treated mice.

Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury

REVIEW ARTICLE: Guilty As Charged: All Available Evidence Implicates Complement’s Role in Fetal Demise

Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia

Role of complement component C1q in the onset of preeclampsia in mice

Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies

Role of tissue factor in feto‐maternal development: a xiphos ⬇️

Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation

Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome

Statins prevent cervical remodeling, myometrial contractions and preterm labor through a mechanism that involves hemoxygenase-1 and complement inhibition.

The Intersection of Maternal Metabolic Syndrome, Adverse Pregnancy Outcomes, and Future Metabolic Health for the Mother and Offspring

The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients

The complement system in the pathophysiology of pregnancy

The role of complement in pregnancy and fetal loss

Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule

Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury

Urinary congophilia in women with hypertensive disorders of pregnancy and preexisting proteinuria or hypertension

Verapamil Protection against Mercuric Chloride-Induced Renal Glomerular Injury in Rats